ArticleLife (Basel, Switzerland)2025
Pilot Study Evaluating the Early Clinical Outcomes Obtained with a Novel, Customized, Multifocal Corneo-Scleral Contact Lens for Presbyopia Correction.
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe objective was to preliminarily evaluate the short-term clinical outcomes obtained in presbyopic patients with a novel, multifocal, customized corneo-scleral contact lens (CSCL).
methodsA total of 11 presbyopic subjects (age 45-80 years, corrected-distance visual acuity ≤ 0.1 LogMAR, near addition ≥ +1.00 D) were recruited and fitted with a multifocal corneo-scleral contact lens in this pilot study. Pre-fitting evaluations included stereopsis, contrast sensitivity (CS), and ocular aberrometry, with follow-up assessments conducted at 20 min and 1-month post-fitting. The defocus curve was also measured to assess visual performance across varying distances.
resultsTwenty-two eyes from 11 participants (53.9 ± 4.7 years, 10 female) were included in this study. Significant changes were observed post-fitting for primary and secondary spherical aberration, coma, and stereopsis (
conclusionsThe customized CSCL evaluated provided functional recovery of visual quality across distances, with acceptable reductions of CS and stereopsis that are comparable to those reported for other multifocal contact lenses.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.